Startup profile · funding coverage
Memora Health funding, valuation and investors
AI care navigation via SMS and phone for complex patients—acquired by Commure in 2024.
Keep track of Memora Health
Save this profile to your VCT watchlist for a quick return.
Funding, valuation & investors
Answer-first snapshotLatest funding
Series C
$30M · April 2023
Latest known valuation
Not publicly disclosed
Total disclosed equity funding
$70M
Excludes debt, grants, acquisitions, secondaries, and IPO proceeds.
Current status
acquired
acquired · San Francisco, California
Investors in latest funding
Lead: General Catalyst
Latest tracked event: Acquired by Commure (December 2024). It is shown separately because it is not counted as disclosed equity funding.
Overview
Memora Health, founded in 2017 from Harvard Innovation Labs by Kunaal Naik, Manik Bhat, and colleagues, built an intelligent care navigation platform automating patient outreach via SMS and phone for complex care journeys—oncology, maternal health, and chronic disease programs. The company raised a $40 million Series B in February 2022 with AlleyCorp and Andreessen Horowitz participating per PR Newswire, followed by a $30 million Series C in April 2023 led by General Catalyst per Axios (~$80M total raised). On December 20, 2024, Commure acquired Memora Health to integrate care navigation into its AI-powered patient engagement and clinical documentation portfolio per Commure press release.
Why Memora Health is interesting
Harvard Innovation Labs-born Memora automated oncology and chronic-care outreach; a16z and AlleyCorp backed $70M+ in venture before Commure folded it into an AI health stack in Dec 2024.
Product & use cases
Memora automates two-way patient communication—symptom triage, appointment prep, medication reminders—routing escalations to the right clinical staff via EHR-integrated workflows.
- Oncology care pathways with automated check-ins
- Post-discharge follow-up reducing readmissions
- Health plan member navigation for complex chronic patients
Key facts
- Series B (Feb 2022): $40M; a16z and AlleyCorp participated (PR Newswire)
- Series C (Apr 2023): $30M led by General Catalyst (Axios)
- Acquired Dec 20, 2024 by Commure (Commure press release)
- ~$80M total venture raised per PitchBook/FierceHealthcare
Funding history (newest first)
Acquired by Commure
2024-12 Not disclosedSeries C
2023-04 $30MSource: https://www.axios.com/2023/04/06/memora-health-series-c-general-catalyst
Investors in our directory
Funds linked from Memora Health's profile — open a fund page for stage focus and related deal articles.
Competitive landscape
Edge: SMS-first outreach with clinical workflow integration—meeting patients on phones, not only patient portal apps with low engagement.
Care navigation bots became table stakes for health systems post-COVID. Memora scaled on SMS engagement; Commure acquisition reflects consolidation as AI documentation and navigation merge under platform buyers.
-
Luma Health / Artera direct
Patient communication and scheduling platforms for health systems.
-
Notable Health adjacent
Clinical automation; overlapping health system buyers.
-
Commure (acquirer) incumbent
Combined Memora navigation with Commure engagement stack post-2024.
Notable stories
- Originated at Harvard Innovation Labs focusing on discharge follow-up gaps (FierceHealthcare).
- Commure CEO Tanay Tandon cited unified patient journey as acquisition thesis (GlobeNewswire).
- Co-founder Kunaal Naik remained as CTO post-acquisition per Commure announcement.
Industries
Related funding articles
Venture Capital Tracker pieces that cover Memora Health's financing or category context.
FAQs about Memora Health
Practical answers founders, operators, and investors typically search for.
Last updated:
Editorial note: AI tools assisted with research, structure, or drafting. Venture Capital Tracker retains human editorial responsibility for factual accuracy, relevance, and source quality before publication.